TotalMarketCap

Novartis

NVSNYSE SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$308.987 B

$161.93 -1.85%

Close of 6 Nov 2026

As of 6 Nov 2026, Novartis (NVS) has a market capitalization of $309.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,908,151,679

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #3AbbVieABBV$510.3B
  2. #4Merck & Co.MRK$362.2B
  3. #5NovartisNVS$309.0B
  4. #6AstrazenecaAZN$290.1B
  5. #7Abbott LaboratoriesABT$197.0B

What if Novartis were worth as much as…

Open the what-if tool →

Gold $28.2T

$14,798.02

Per share 91.4× higher

Bitcoin $1.53T

$800.70

Per share 4.94× higher

Apple $5.02T

$2,628.61

Per share 16.2× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Novartis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.